NCT02332330View on ClinicalTrials.gov

CD0104 VEST II Post Marketing Surveillance Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

April 30, 2016

Conditions
Coronary Artery Bypass Surgery
Interventions
DEVICE

VEST

Trial Locations (2)

Unknown

Krankenhaus der Barmherzigen Bruder, Trier

The John Radcliffe Hospital, Oxford

All Listed Sponsors
lead

Vascular Graft Solutions Ltd.

INDUSTRY

NCT02332330 - CD0104 VEST II Post Marketing Surveillance Study | Biotech Hunter | Biotech Hunter